Dr. Konrad Faulstich

Angestellt, Senior Director Strategy and Corporate Development, BioNTech SE

Mainz, Deutschland

Werdegang

Bis heute 10 Jahre und 6 Monate, seit Apr. 2014
Senior Director Strategy and Corporate Development
BioNTech SE
Bis heute
Vice President Research and Scientific Affairs
Xagenic
VP, Point-of-Care technologies, Scientific Affairs, Strategic, Regulatory, Quality Management, IP / Technology Management, Clinical Study Management, Product Development and Validation
Director Strategic Alliances
QIAGEN, Germany
responsible for Business to Business (B2B) and OEM in Asia Pacific and selected accounts worldwide, numerous deals with governments, industry, academia and supranational institutions located in Stockach and Duesseldorf, Germany
Head of Business Development
ESE (acquired by QIAGEN), Germany
Strategic Management, Business Development, Marketing, Sales, Application Laboratory, Technology / IP Management Worldwide responsibility located in Stockach, Germany
Manager
Applied Biosystems (now Life Technologies), USA
Manager in Advanced Research and Technology Division, Multi-site and -group responsibility, located in Foster City, California, USA
Group Leader
Becton Dickinson, USA
Product Development, Group Leader in Gene Cloning and Analysis Department of Becton Dickinson, located in the Biosciences Clontech Division in Palo Alto, California, USA
Scientist / Staff Member
European Molecular Biology Laboratory (EMBL), Germany

Business
Cardean University (renamed John Hancock University)
Strategy / Finance / Economics
Chemistry
Johann Wolfgang Goethe Universität Frankfurt am Main
Bio-Organic Chemistry, Nucleic Acid Chemistry

21 Mio. XING Mitglieder, von A bis Z

Nachname: